
Jun 4, 2026 · 12 min · 9 segments
As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. Jonathan Chou discusses targeted therapies. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41563]
Jonathan ChouGuest
So of course, when I was putting together this talk, I asked ChatGPT, What is targeted therapy for prostate cancer? And I thought ChatGPT actually gave an excellent response, much better and much more eloquent than I could have given.

And what ChatGPT said was, in oncology, targeted therapy refers to cancer treatments that are designed to specifically identify and attack molecular features of the cells.

rather than broadly killing all rapidly dividing cells like traditional chemotherapy does, okay? And so the key idea here is that we're going to need to understand the unique genetic mutations or abnormal proteins that might drive the prostate cancer to grow, And that we're going to build therapies that are targeted to interfere with those specific abnormalities.

And so how does this actually work? So at a very high level, what we're thinking about are what are the mutated genes in prostate cancer, okay? And I've just listed a couple.

The androgen receptor, which is what testosterone binds to, can be mutated in prostate cancer.

Ivan just talked about PSMA targeting in prostate cancer, so proteins that are outside on the surface of the prostate cancer cells that we might be able to target, and then various different signaling pathways that might control growth, and we'll talk a little bit about what those might be.

So of course, when I was putting together this talk, I asked ChatGPT, What is targeted therapy for prostate cancer? And I thought ChatGPT actually gave an excellent response, much better and much more eloquent than I could have given.

And what ChatGPT said was, in oncology, targeted therapy refers to cancer treatments that are designed to specifically identify and attack molecular features of the cells.

rather than broadly killing all rapidly dividing cells like traditional chemotherapy does, okay? And so the key idea here is that we're going to need to understand the unique genetic mutations or abnormal proteins that might drive the prostate cancer to grow, And that we're going to build therapies that are targeted to interfere with those specific abnormalities.

And so how does this actually work? So at a very high level, what we're thinking about are what are the mutated genes in prostate cancer, okay? And I've just listed a couple.

The androgen receptor, which is what testosterone binds to, can be mutated in prostate cancer.

Ivan just talked about PSMA targeting in prostate cancer, so proteins that are outside on the surface of the prostate cancer cells that we might be able to target, and then various different signaling pathways that might control growth, and we'll talk a little bit about what those might be.
The rest of this transcript — segmented and speaker-labeled, so you land on the exact moment something was said
Search every transcript — by keyword, by phrase, or by meaning, across every show Radar indexes
Trends — what is surging across podcasts, measured against its own baseline
Alerts — when a name you follow appears in a newly indexed episode
No account is needed to search Radar.